Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

163.73
+3.562.22%
Post-market: 163.783.61+2.25%16:00 EDT
Volume:3.08M
Turnover:504.19M
Market Cap:253.95B
PE:24.51
High:164.53
Open:164.05
Low:162.14
Close:160.17
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.89
T/O Rate:0.21%
Dividend:3.17
Dividend Rate:1.94%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.05
PE(LYR):25.04

Loading ...

Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition

Benzinga Earnings
·
Jul 27

AstraZeneca Sees Potential for AI Beyond Drug Discovery

Dow Jones
·
Jul 27

AstraZeneca Wants to Move at 'Chinese Speed,' CEO Says

Dow Jones
·
Jul 27

Europe Faces Competition for Pharma Investment, AstraZeneca CEO Says

Dow Jones
·
Jul 27

Europe, Japan are Falling Behind on Pharma Innovation, AstraZeneca CEO Says

Dow Jones
·
Jul 27

AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth

Dow Jones
·
Jul 27

Press Release: AstraZeneca Results: H1 and Q2 2026

Dow Jones
·
Jul 27

AstraZeneca ‘on track’ to deliver ambition of $80B in revenue in 2030

TIPRANKS
·
Jul 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 27

Stocks to Watch: CXMT, LVMH, Nvidia, Chevron

Dow Jones
·
Jul 27

Astrazeneca's Ultomiris Misses Primary Goal in Late-Stage Rare-Disease Trial

MT Newswires Live
·
Jul 27

AstraZeneca Reports 'Positive' Phase 3 Results for Sonesitatug Vedotin in Claudin 18.2-Positive Gastric Cancers

MT Newswires Live
·
Jul 27

AstraZeneca Q2 Core Earnings, Revenue Rise

MT Newswires Live
·
Jul 27

AstraZeneca Results Should Allay Investor Fears

Dow Jones
·
Jul 27

AstraZeneca Beats Q2 Earnings Estimates, Focus Shifts to Next-Generation Oncology Drug Pipeline

Stock News
·
Jul 27

AstraZeneca Q2 Adj. EPS $2.63 Beats $2.48 Estimate, Sales $15.384B Miss $15.459B Estimate

Benzinga Earnings
·
Jul 27

AstraZeneca Beats Second-Quarter Profit Expectations, Holds Outlook

Reuters
·
Jul 27

Movement Alert|AstraZeneca PLC Rises 5.33% Overnight, Q2 Earnings Beat Market Expectations

Market Focus
·
Jul 27

Astrazeneca Q2 Revenue Rises 6% on Demand for Its Cancer Therapies

Reuters
·
Jul 27

Astrazeneca PLC Stock Rises Friday, Underperforms Market

Dow Jones
·
Jul 25